LD-38 is a drug-linker conjugate designed for antibody-drug conjugate (ADC) applications. It combines a topoisomerase I inhibitor, Exatecan, with a stable, cleavable linker that enhances hydrophilicity. This compound is ideal for the synthesis of various ADCs, including KA-3123-LD38, and is utilized in research focusing on targeted cancer therapies and drug delivery systems.
LD-38 is a drug-linker conjugate designed for antibody-drug conjugate (ADC) applications. It combines a topoisomerase I inhibitor, Exatecan, with a stable, cleavable linker that enhances hydrophilicity. This compound is ideal for the synthesis of various ADCs, including KA-3123-LD38, and is utilized in research focusing on targeted cancer therapies and drug delivery systems.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula: